A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation

NCT02156076 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

158

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision based on business reasons, unrelated to safety

Conditions

Paroxysmal Atrial Fibrillation

Interventions

DRUG: BMS-919373
DRUG: Placebo (Matching with BMS-919373)

Sponsor

Bristol-Myers Squibb